Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards' TAVR Platforms Challenged In Boston Scientific Patent Suits

This article was originally published in The Gray Sheet

Executive Summary

More patent litigation is emerging in the transcatheter aortic valve replacement space with two recent lawsuits alleging that Edwards Lifesciences' Sapien 3 TAVR device and delivery systems violated a total of nine patents held by Boston Scientific.

You may also be interested in...



Medtronic Wins Physician-Filed TAVR Patent Suit

The US Court of Appeals for the Federal Circuit upheld a Patent Trial & Appeals Board ruling against a doctor who claimed to be the true inventor of technology used in the CoreValve transcatheter aortic heart valve replacement device.

Medtronic Will Pay Edwards More Than $1 Billion To Settle TAVR Dispute

A settlement between the two companies dismissing all pending patent litigation related to transcatheter valve replacement technologies ends years of legal wrangling and ensures that the U.S. TAVR market will have at least two competitors.

Lotus Launches In Europe: Boston Scientific Joins Crowded TAVR Field

The firm announced the CE mark and European launch of its transcatheter aortic heart valve replacement device Oct. 28. Boston is one of at least seven firms with a TAVR device now on the market in Europe.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel